LifeMD, Inc. Financial Ratios
LFMD|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Altman Z-Score 1.60 (gray zone, between 1.23 and 2.9)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-92.5%
Profit Margin
-13.8%
Net Income / Revenue
Asset Turnover
2.20
Revenue / Total Assets
Equity Multiplier
3.04
Total Assets / Equity
Composite: -92.5% (reported: -92.5%)
Profitability
Liquidity
Current Ratio
1.25
Quick Ratio
1.18
Solvency
Interest Coverage
8.05
Efficiency
Asset Turnover
2.20
Inventory Turnover
7.73
Days Sales Outstanding
22 days
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026
Earnings Quality
Accrual Ratio
-54.5%
-13.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.